本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Forte BioSciences Inc

13.66
-0.1800-1.30%
盘后13.660.00000.00%16:40 EDT
成交量:2.37万
成交额:32.96万
市值:1.67亿
市盈率:-1.66
高:14.49
开:13.84
低:13.35
收:13.84
数据加载中...
2024/08/30

重要事件披露

Form 8-K - Current report
2024/08/22

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

重要事件披露

Form 8-K - Current report
2024/06/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/29

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/02/16

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/09

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]